Immuron Limited (ASX:IMC)
Australia flag Australia · Delayed Price · Currency is AUD
0.0350
+0.0060 (20.69%)
Apr 17, 2026, 3:57 PM AEST

Immuron Revenue

Immuron had revenue of 4.18M AUD in the half year ending December 31, 2025, with 77.64% growth. This brings the company's revenue in the last twelve months to 7.48M, up 14.30% year-over-year. In the fiscal year ending June 30, 2025, Immuron had annual revenue of 7.29M with 48.63% growth.

Revenue (ttm)
7.48M
Revenue Growth
+14.30%
P/S Ratio
1.53
Revenue / Employee
1.07M
Employees
7
Market Cap
11.43M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20257.29M2.38M48.63%
Jun 30, 20244.90M3.10M171.67%
Jun 30, 20231.80M1.04M135.85%
Jun 30, 2022765.19K619.42K424.91%
Jun 30, 2021145.78K-2.37M-94.21%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Neurotech International7.07M
Tissue Repair3.38M
Acrux2.81M
Nexalis Therapeutics986.43K
AdAlta608.07K
Bio-Gene Technology390.63K
Invex Therapeutics229.08K
Patrys100.38K
Revenue Rankings